本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sarepta Therapeutics

17.44
-0.4100-2.30%
盘前:17.480.0400+0.23%08:05 EDT
成交量:328.28万
成交额:5,764.09万
市值:18.41亿
市盈率:-13.25
高:18.14
开:17.88
低:17.30
收:17.85
52周最高:24.68
52周最低:14.68
股本:1.06亿
流通股本:9,905.26万
量比:1.15
换手率:3.31%
股息:- -
股息率:- -
每股收益(TTM):-1.3161
每股收益(LYR):-7.1300
净资产收益率:-9.48%
总资产收益率:-1.13%
市净率:1.21
市盈率(LYR):-2.45

数据加载中...

2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/25

关联方拟减持公告

Form144|赛普拉高管Bilal Arif拟减持3898股,总价约63.9万美元
2024/06/25

关联方拟减持公告

Form144|赛普拉高管Ryan Brown拟减持38957股,总价约638万美元
2024/06/24

关联方拟减持公告

Form144|赛普拉高管Bilal Arif拟减持7859股,总价约126万美元
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities